Summit Therapeutics Inc (NASDAQ:SMMT) has a beta value of -1.05 and has seen 3.57 million shares traded in the last trading session. The company, currently
During the last session, Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares were 2.75 million, with the beta value of the company hitting -1.05. At the end
In the last trading session, 2.38 million shares of the Summit Therapeutics Inc (NASDAQ:SMMT) were traded, and its beta was -1.05. Most recently the company’s
Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares stood at 3.64 million during the last session, with the company’s beta value hitting -1.05. At the close of
In the last trading session, 3.91 million Summit Therapeutics Inc (NASDAQ:SMMT) shares changed hands as the company’s beta touched -1.05. With the company’s per share
In last trading session, Summit Therapeutics Inc (NASDAQ:SMMT) saw 6.19 million shares changing hands with its beta currently measuring -1.05. Company’s recent per share price
Summit Therapeutics Inc (NASDAQ:SMMT) has a beta value of -0.94 and has seen 19.8 million shares traded in the last trading session. The company, currently
In the last trading session, 2.22 million shares of the Summit Therapeutics Inc (NASDAQ:SMMT) were traded, and its beta was -0.95. Most recently the company’s
Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares stood at 4.39 million during the last session, with the company’s beta value hitting -0.97. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne